• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Permira

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
Cloud business management solutions providers
Options Technology draws Permira's interest as Abry Partners collects refreshed bids

GP could roll some of its stake over as part of sale of UK-based IT services business

  • Exits
  • 10 August 2023
Pharmaceutical and biotech services providers
Permira early strong contender in Triton-backed Pharmanovia auction

Speciality pharma business sale comes as a number of other large-cap healthcare auctions have faltered

  • Exits
  • 28 July 2023
Peer-to-peer lending
Portable refis pave way for smoother sponsor exits in rocky market

Sellers are aiming to bolster buyer confidence, securing debt that can be transferred to the next LBO

  • Financing
  • 10 July 2023
Golden Goose is a designer of high-end trainers
Advisors court Permira for Golden Goose stake sale as alternative to IPO

A slew of Italian and international banks are trying to get in front of Permira to help the Golden Goose Spa majority shareholder refine its thinking around exit options, three sources told Unquote sister publication Mergermarket, adding that some were...

  • Exits
  • 28 June 2023
Designer accessories and fashion retailers
Permira to acquire majority stake in Gruppo Florence

Existing shareholders including VAM Investments and management of the Italian fashion group will reinvest, while Italmobiliare will exit

  • Buyouts
  • 26 May 2023
Fundraising in euros
Permira raises EUR 16.7bn for Fund VIII, 50% up on previous vintage

Final close comes in a market largely devoid of multi-billion fundraises from European managers in recent months

  • Buyout
  • 08 March 2023
Marketing data
Hellman & Friedman kicks off talks for TeamSystem stake sale

Sponsors and sovereign wealth funds have been selected for discussions with the Italian cloud software group

  • Exits
  • 06 March 2023
Stock market trackers and financial investment apps
Equistone to exit Acuity in sale to Permira

Sale of financial services research group follows process with early discussions between vendor and bidders

  • Exits
  • 27 January 2023
Sponsor exits in Europe hit decade low
Going, going, not gone: PE auctions bid for relevance amid risk-off environment

With a debt financing drought and macro woes denting exits, GPs are adapting the traditional M&A auction in favour of more flexible bilateral negotiations to get deals across the line

  • GPs
  • 18 January 2023
Jorg Rockenhauser of Permira
Permira announces changes in DACH leadership

Jörg Rockenhäuser to become region’s first chairman as Florian Kreuzer succeeds him as head of DACH

  • People
  • 21 December 2022
Tokyo in Japan
Permira Advisors shuts down Japan office

GP spokesperson says strategy is unchanged, will pursue opportunities in Japan selectively

  • GPs
  • 21 October 2022
Camping holidays providers
Permira to exit Vacanceselect to PAI-backed European Camping Group

French campsite operator will have approximately 10% market share in Europe after the acquisition

  • Buyouts
  • 01 August 2022
Simon Segars of Permira
Permira hires former Arm CEO as technology adviser

Simon Segars takes on global role to advise the GP and the management of its technology companies

  • People
  • 01 July 2022
Healthcare software
Hg’s MEDIFOX sale launch draws large-cap sponsor interest

Hg acquired the software platform for care providers in 2018 from ECM Equity Capital Management

  • Exits
  • 27 May 2022
MRI scanners
Permira exits Althea to F2i and DWS

Deal will see the Italian group broken into two, with DWS owning the UK arm and F2i the Italian assets

  • Healthcare
  • 11 May 2022
Real estate online searches
Scout24 eyed by buyout groups including H&F, EQT, Permira

The downward trend in its share price has put the German real estate marketplace back on the radar of cash-rich sponsors

  • Buyouts
  • 08 April 2022
Golden Goose is a designer of high-end trainers
Permira's Golden Goose in talks with banks over potential New York IPO

Italian high-end sneakers maker started discussing listing with advisers that helped it with a senior secured bond issuance last year

  • Exits
  • 14 March 2022
Teachers and education
Large-cap sponsors join philanthropic fund-of-funds

Advent, Bain, Cinven, Hg, Nautic and Permira join the scheme

  • Fund-of-funds
  • 25 February 2022
Global payments providers
Permira, Blackrock lead USD 312m round for GoCardless

Europe's new tech unicorn reaches a valuation of USD 2.1bn following latest funding round

  • Expansion
  • 09 February 2022
Mood surveys
Permira leads USD 180m round for GWI

London-headquartered market research software-as-a-service platform is valued at more than USD 850m

  • Expansion
  • 01 February 2022
Computer services and business enterprise software
TeamViewer attracted take-private interest last year amid PE boom

Frankfurt flotation of TeamViewer in 2019 delivered a bonanza for backer Permira

  • Exits
  • 24 January 2022
Biotech drug discovery companies
Permira merges Kedrion, BPL

Combined biotechnology group will have more than EUR 1.1bn in revenues and 4,000 employees

  • Buyouts
  • 20 January 2022
1 2 3
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013